Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.DSM to acquire Polymer Technology Group
The acquisition is subject to regulatory approvals and is expected to close in second quarter of 2008. The acquisition price, which will not be disclosed as agreed between
The acquisition is subject to regulatory approvals and is expected to close in second quarter of 2008. The acquisition price, which will not be disclosed as agreed between
Under the terms of the agreement, ChemDiv will discover small molecule ligands for biotargets nominated by Syndexa. Financial terms of the collaboration were not disclosed. Teo Uysal, president
This line extension further extends the brand franchise of Lupin’s flagship anti-infective brand Suprax (Cefixime for oral suspension 100mg/5ml and 200mg/5ml). Suprax 400mg tablets will be promoted by
Study results showed that across all dose groups in the study population, the 6.6 mean letter gain in visual acuity achieved versus baseline at the week 16 evaluation
Advance is a comprehensive platform for the performance of traditional nerve conduction studies and invasive electromyography procedures. The device is intended to be used by physicians to perform
Treximet is said to be the first and only migraine product designed to target multiple mechanisms of migraine by combining a triptan, and an anti-inflammatory pain reliever in
Elixir’s rights to this patent were made possible through an exclusive license. Sirtuins are a class of enzymes believed to play a significant role in diseases of aging,
Teva’s approval is for the 0.5mg base/vial and 1.5mg base/vial strengths as well as the sterile diluent. This product is indicated for the long term intravenous treatment of
Imagify is an ultrasound imaging agent for the detection of coronary artery disease. The new drug application (NDA) includes data from studies of Imagify in more than 1,000
In the FDA’s letter, the agency rejected the proposed trade name Cordaptive for MK-0524A (ER niacin/laropiprant). The company said at the appropriate time it expects to pursue the